Pricing Log in Create free account

Acurx Pharmaceuticals, Inc. (ACXP) vs FibroBiologics Inc. (FBLG)

Acurx Pharmaceuticals, Inc. and FibroBiologics Inc. are both Biotechnology companies. Acurx Pharmaceuticals, Inc. and FibroBiologics Inc. are of similar size ($6.7M and $6.5M). Across the 9 metrics below, Acurx Pharmaceuticals, Inc. leads on 8 and FibroBiologics Inc. on 1.

Valuation

Metric ACXP FBLG Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.57 1.29 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.78 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (244.55%) (546.32%) (33.15%)
Free cash flow yield (131.97%) (252.58%) (25.50%)

Profitability

Metric ACXP FBLG Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (128.11%) (660.08%) (56.36%)
Return on assets (87.57%) (166.14%) (48.04%)
Return on invested capital 0.00% (932.71%) 0.00%

Growth

Metric ACXP FBLG Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 69.43% (23.53%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACXP FBLG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.88 2.64 4.72
Net debt to EBITDA 0.93 0.31 0.96

Dividend

Metric ACXP FBLG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACXP FBLG Biotechnology median
Market cap 6.50m 6.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack